Abstract
Evaluating Disparities in Proton Radiation Therapy Use in AHOD1331, a Contemporary Children's Oncology Group Trial for Advanced-Stage Hodgkin Lymphoma.
Highlights
To the Editor: The indications for proton radiation therapy carry the strongest evidence in pediatric cancers
In a recently published letter, Bitterman et al [1] reviewed factors associated with receipt of proton radiation therapy in patients enrolled in Children’s Oncology Group (COG) solid tumor and CNS tumor trials
Within the context of Hodgkin lymphoma, especially for patients with large mediastinal adenopathy (LMA), dose reduction is important for at-risk organs, including the lungs, heart, and breasts [2, 3]
Summary
In a recently published letter, Bitterman et al [1] reviewed factors associated with receipt of proton radiation therapy in patients enrolled in Children’s Oncology Group (COG) solid tumor and CNS tumor trials. They demonstrated that Black children were less likely to receive this treatment than non-Hispanic white patients, a disparity that persisted when controlling for other demographic and clinical variables. As radiation oncologists are highly specialized, it is rare for them to primarily diagnose cancers, in the pediatric setting Unequal access reflects those obstacles or biases acting on (1) the relationship between pediatric oncologist and radiation oncologist; (2) the recommendation of radiation oncologist; or (3) patient choice.
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
